COMMUNIQUÉ DE PRESSE publié le 14/08/2025 à 07:00, il y a 1 année 2 mois Relief Therapeutics Publishes 2025 Half-Year Report Relief Therapeutics published its 2025 half-year report, highlighting progress in pipeline candidates for rare diseases and financial status. Corporate update includes advances in wound care and liquid formulation for phenylketonuria Financial Status Relief Therapeutics Rare Diseases 2025 Half-Year Report Pipeline Candidates
COMMUNIQUÉ DE PRESSE publié le 14/08/2025 à 07:00, il y a 1 année 2 mois Wacker Neuson Group publishes Half-year Report and confirms the guidance for the financial year 2025 Wacker Neuson Group publishes Half-year Report for H1/2025, confirming guidance for 2025. Revenue at EUR 1,074.9 million, EBIT margin at 5.2%. Free cash flow positive at EUR 67.7 million Revenue Half-year Report EBIT Margin Wacker Neuson Group Financial Year 2025
COMMUNIQUÉ DE PRESSE publié le 14/08/2025 à 07:00, il y a 1 année 2 mois Brockhaus Technologies AG: Revenue rises in H1 2025 by +2.6% to €112 million with adjusted EBITDA of €25 million – 2025 outlook confirmed Brockhaus Technologies AG reports +2.6% revenue growth in H1 2025 to €112 million, adjusted EBITDA at €25 million, confirmed outlook for 2025 Adjusted EBITDA Revenue Growth Brockhaus Technologies AG 2025 Outlook H1 2025
COMMUNIQUÉ DE PRESSE publié le 14/08/2025 à 07:00, il y a 1 année 2 mois Communiqué de presse : Le rilzabrutinib de Sanofi obtient la désignation de médicament orphelin dans l’UE pour la maladie liée aux IgG4 Sanofi obtient la désignation de médicament orphelin pour le rilzabrutinib dans l'UE contre la maladie liée aux IgG4. Étude de phase 2 positive présentée à l'EULAR 2025 États-Unis Sanofi Médicament Orphelin Rilzabrutinib Maladie IgG4
COMMUNIQUÉ DE PRESSE publié le 14/08/2025 à 07:00, il y a 1 année 2 mois Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease Sanofi’s rilzabrutinib granted orphan designation in EU for IgG4-related disease. Positive Phase 2 results presented at EULAR 2025 Congress showcasing efficacy and safety profile Sanofi Rilzabrutinib Orphan Designation IgG4-related Disease EULAR 2025
COMMUNIQUÉ DE PRESSE publié le 14/08/2025 à 06:59, il y a 1 année 2 mois grenke AG: First half-year 2025 on track grenke AG reports on track first half-year 2025 with earnings of EUR 26.2 million, improved cost-income ratio, and acquisition progress Acquisition Earnings GRENKE AG Cost-income Ratio First Half-year 2025
COMMUNIQUÉ DE PRESSE publié le 14/08/2025 à 06:58, il y a 1 année 2 mois H1 2025: ProCredit firmly in execution phase of its growth and transformation strategy whilst delivering good financial results ProCredit Holding AG reports strong financial results and implementation progress of growth strategy for H1 2025 in Southeastern and Eastern Europe Growth Strategy Financial Results ProCredit Holding AG H1 2025 Southeastern And Eastern Europe
COMMUNIQUÉ DE PRESSE publié le 14/08/2025 à 06:00, il y a 1 année 2 mois Successor for division president of Bucher Emhart Glass Bucher Industries appoints Daniel Schippan as division president of Bucher Emhart Glass. Matthias Kümmerle to become CEO of Bucher Industries in 2026 Acquisition Bucher Industries Glass Industry Daniel Schippan Matthias Kümmerle
COMMUNIQUÉ DE PRESSE publié le 14/08/2025 à 06:00, il y a 1 année 2 mois Schlatter achieves a slightly positive operating result and a negative consolidated result in the first half of 2025. A profit is targeted for the year as a whole. Schlatter achieves slightly positive operating result but reports negative consolidated result in H1 2025. Targeting full-year profit amid challenging market conditions Financial Performance Market Challenges Schlatter Industries AG Operating Result Consolidated Result
COMMUNIQUÉ DE PRESSE publié le 14/08/2025 à 02:05, il y a 1 année 2 mois Nepra Foods Provides Bi-Weekly MCTO Status Report Nepra Foods Inc. announces extension for filing annual financial statements. Management cease trade order granted by BCSC until September 29, 2025. Shareholders' trading unaffected Shareholders Financial Statements Management Cease Trade Order BCSC Nepra Foods Inc.
Publié le 10/11/2026 à 18:00, il y a 21 heures 24 minutes Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Publié le 10/11/2026 à 17:45, il y a 21 heures 39 minutes Damartex / Descriptif du programme de rachat d'actions
Publié le 10/11/2026 à 17:35, il y a 21 heures 49 minutes ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Publié le 10/11/2026 à 17:31, il y a 21 heures 52 minutes CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.
Publié le 11/11/2026 à 14:00, il y a 1 heure 24 minutes PPX Mining Reports Callanquitas Operating Results for the First Nine Months of 2026
Publié le 11/11/2026 à 14:00, il y a 1 heure 24 minutes NuRAN Wireless Board Approves Growth Strategy to Scale Recurring Revenue from 5,000+ Contracted Towers
Publié le 11/11/2026 à 13:15, il y a 2 heures 9 minutes Amarc Extends 2026 Exploration Program at the Duke District: Initiates Drilling Program at Established Porphyry Copper-Gold Targets
Publié le 11/11/2026 à 13:00, il y a 2 heures 24 minutes NiobiumX Mining Reports Results of Ground Radiometric Survey at Shipshaw, Maps Two Distinct Radiometric Signatures Across the Core Claims, and Moves to a High-Resolution Airborne Survey of the Full 2,686-Hectare Package
Publié le 11/11/2026 à 15:05, il y a 19 minutes Cyient, 3-GIS Partner to Help Telecom and Utility Operators Turn Network Data into Operational Control